期刊文献+

NT-proBNP结合组织多普勒技术评估舒张性心力衰竭的研究 被引量:7

Evaluation of NT-proBNP and tissue Doppler imaging in patients with diastolic heart failure
原文传递
导出
摘要 目的:探讨N末端脑利钠肽前体(NT-proBNP)结合二尖瓣舒张早期血流峰速度/二尖瓣环舒张早期运动峰速度(E/Ea)在诊断和评估舒张性心力衰竭(DHF)中的作用。方法:将我科收治的80例DHF患者作为DHF组,同时根据NYHA心功能分级分为NYHAⅡ级、NYHAⅢ级、NYHAⅣ级3个亚组,另选取同期住院或体检心功能正常者23例为对照组。分别对各组行血流频谱多普勒及组织多普勒超声心动图检测。同期检测血清NT-proBNP浓度、血清高敏C反应蛋白(hs-CRP)、血脂等,并对结果进行统计学处理。结果:与对照组相比,DHF组患者E/Ea、NT-proBNP显著升高(P<0.001)。随着心力衰竭程度的加重,NT-proBNP浓度和E/Ea比值逐渐升高。多元回归分析显示,lg NT-proBNP水平与左室E/Ea独立相关(β=0.267,P<0.01),与LVEF明显负相关(β=-0.440,P<0.001)。NT-proBNP联合E/Ea比值诊断DHF时特异度、阳性预测值、阳性拟然比均较单独应用NT-proBNP或E/Ea时高。结论:血清NT-proBNP浓度检测结合组织多普勒超声检测E/Ea值,可协助诊断DHF和评价左室功能。 Objective :To investigate the role of (NT-proBNP) combined with the ratio of mitral peak velocity of early filling to early diastolic mitral annular velocity (E/Ea) in the diagnosis and evaluation of patients with di- astolic heart failure (DHF). Metbod: A total of 80 hospitalized patients with DHF were divided into NYHA Ⅱ group,NYHAⅢ group and NYHA Ⅳ group according to NYHA heart function. In the same period, 23 patients with normal heart function were selected as control group. Conventional and tissue Doppler imaging was tested by echocardiography. NT-proBNP, high-sensitive C reactive protein (hs-CRP) and lipids were detected in blood. Result : Compared with control group, both E/Ea and NT-proBNP were significantly higher in DHF group (both P〈 0. 001), and increased gradually with the severity of heart failure. Multiple regression analysis showed that lg NT-proBNP level was independently associated with left ventricular E/Ea (β=0. 267, P〈0.01), while was obviously and negatively correlated with LVEF (β= -0. 440, P〈0. 001). The specificity, positive predictive value, and positive likelihood ratio to diagnose DHF were higher by using NT-proBNP and E/Ea combinedly than application separately. Conclusion : Serum NT-proBNP detecting, combined with E/Ea ratio testing by tissue Doppler ultrasound, could be helpful to diagnose DHF and evaluate left ventricular function.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2015年第2期176-179,共4页 Journal of Clinical Cardiology
基金 重庆市科委自然科学基金面上项目(No:CSTC2009BB5405) 重庆市卫生局医学科研计划项目(No:2013-2-010) 国家自然科学基金项目(No:81300140)
关键词 舒张性心力衰竭 二尖瓣舒张早期血流峰速度/二尖瓣环舒张早期运动峰速度 N末端脑利钠肽前体 diastolic heart failure mitral peak velocity of early filling/early diastolic mitral annular velocity N-terminal pro-brain natriuretic peptide
  • 相关文献

参考文献7

  • 1LIS W J,CARSTEN J C,SANDERSON J E,et al. How to diagnose diastolic heart failure, a consensus statement on the diagosis, of heart failure with normal left ventricu- lar ejection fraction by the Heart Failure and Society of Cardiology [J] Eur Heart J, 2007,28 : 253g- 2550.
  • 2Alan Maise,Christian Mueller,W. Frank Peacock,Gerasimos Filippatos,Hu Dayi,胡大一(主译),刘梅颜(主译),吴寸草(翻译),王博雅(翻译),黄睿(翻译).2008中西方BNP专家共识[J].中国医药导刊,2009,11(10):1628-1637. 被引量:77
  • 3中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122. 被引量:4689
  • 4MOTTRAM P M, HALUSKA B, LOANO R, et al. Effect of aldosterone antagonism on myocardial dys- function in hypertensive patients with diastolic heart failure[J]. Circulation, 2004,110 : 558- 565.
  • 5王瑶,陶则伟,陆贤,黄元伟.B型钠尿肽的研究进展[J].心脏杂志,2003,15(6):555-557. 被引量:41
  • 6RIVAS-GOTZ C, MANOLIOS M, THOHAN V, NAGUEH SF. Impact of lef ventricular ejection frac- tion on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity [J]. Am J Cardiol, 2003,91,780-784.
  • 7BELAGAVI AC1, RAO M, PILLAI AY, et al. Cor- relation between NT proBNP and left ventricular ejec- tion fraction in elderly patients presenting to emergen- cy department with dyspnoea[J]. Indian Heart J. 2012 May-Jun,64(3) :302-304.

二级参考文献113

  • 1Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulatinn, 2002; 105(5):595-601.
  • 2Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol, 2004;43:1590-1595.
  • 3Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation, 2004;109:594-600.
  • 4Daniels LB, Clopton P, Bhalla V, et al. How obesity affects the cut-points for B-type natrinretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study, Am Heart J,2006;151 :1006-1012.
  • 5Sarzani R, Dessi-Fulgheri P, Paci VM, et al.Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest, 1996;19:581-585.
  • 6Horwich TB, Hamilton MA, Fonarow GC. B-type natrinretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol, 2006;47:85-90.
  • 7Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, et al. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal probrain natriuretic peptide in patients with acute dyspnea. Arch Intern Med, 2007; 167:400-407.
  • 8Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 1993;87:464-469.
  • 9Leya FS, Arab D, Joyal D, et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol, 2005;45:1900-1902.
  • 10Babuin L, Alegria JR, Oh JK, et al.Brain natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. J Am Coll Cardiol, 2006;47:1489-1491.

共引文献4799

同被引文献71

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部